Efficacy and safety of nanoliposomal irinotecan plus fluorouracil and folinic acid after irinotecan-based chemotherapy in patients with advanced pancreatic cancer: Results of the retrospective part of the NAPOLEON-2 study.

被引：0
|
作者：
Kawaguchi, Yasunori
Aikawa, Tomomi
Shimokawa, Mototsugu
Otsuka, Taiga
Shibuki, Taro
Nakazawa, Junichi
Arima, Shiho
Miwa, Keisuke
Koga, Futa
Ueda, Yujiro
Kubotsu, Yoshihito
Shimokawa, Hozumi
Takeshita, Shigeyuki
Nishikawa, Kazuo
Hosokawa, Ayumu
Oda, Hisanobu
Sakai, Tatsunori
Shirakawa, Tsuyoshi
Mizuta, Toshihiko
Mitsugi, Kenji
机构：
[1] Asakura Med Assoc Hosp, Asakura, Japan
[2] Japan Community Healthcare Org Kyushu Hosp, Kitakyushu, Fukuoka, Japan
[3] Yamaguchi Univ, Grad Sch Med, Dept Biostat, Yamaguchi, Japan
[4] Minato Med Clin, Fukuoka, Japan
[5] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan
[6] Kagoshima City Hosp, Kagoshima, Japan
[7] Kagoshima Univ, Grad Sch Med & Dent Sci, Kagoshima, Japan
[8] Kurume Univ Hosp, Kurume, Fukuoka, Japan
[9] Saga Med Ctr Koseikan, Saga, Japan
[10] Japanese Red Cross Kumamoto Hosp, Kumamoto, Japan
[11] Karatsu Red Cross Hosp, Karatsu, Japan
[12] Japanese Red Cross Nagasaki Genbaku Hosp, Nagasaki, Japan
[13] Oita Univ, Fac Med, Yufu, Japan
[14] Univ Miyazaki Hosp, Dept Clin Oncol, Miyazaki, Japan
[15] Saiseikai Kumamoto Hosp, Kumamoto, Japan
[16] Natl Hosp Org Kumamoto Med Ctr, Kumamoto, Japan
[17] Karatsu Higashimatsuura Med Assoc Ctr, Karatsu, Japan
[18] Fujikawa Hosp, Saga, Japan
[19] Sasebo Kyosai Hosp, Sasebo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
705
引用
收藏
页码：705 / 705
页数：1
相关论文
共 50 条
  • [1] Interim analysis of the NAPOLEON-2 study: Safety evaluation of nanoliposomal irinotecan with fluorouracil and folinic acid for unresectable pancreatic cancer patients with prior biliary drainage
    Koga, F.
    Shirakawa, T.
    Shimokawa, M.
    Otsuka, T.
    Shimokawa, H.
    Nakazawa, J.
    Oda, H.
    Takeshita, S.
    Kawaguchi, Y.
    Arita, S.
    Taguchi, H.
    Sakai, T.
    Nishikawa, K.
    Arima, S.
    Ueda, Y.
    Kawahira, M.
    Sakae, T.
    Ide, Y.
    Mizuta, T.
    Mitsugi, K.
    ANNALS OF ONCOLOGY, 2023, 34 : S1534 - S1534
  • [2] A multicenter retrospective observational NAPOLEON2 study of nanoliposomal irinotecan with fluorouracil and folinic acid in patients with unresectable pancreatic cancer
    Kodama, Tomoko
    Imajima, Takashi
    Shimokawa, Mototsugu
    Otsuka, Taiga
    Kawahira, Masahiro
    Nakazawa, Junichi
    Hori, Takeshi
    Shibuki, Taro
    Arima, Shiho
    Ido, Akio
    Miwa, Keisuke
    Okabe, Yoshinobu
    Koga, Futa
    Ueda, Yujiro
    Kubotsu, Yoshihito
    Shimokawa, Hozumi
    Takeshita, Shigeyuki
    Nishikawa, Kazuo
    Komori, Azusa
    Otsu, Satoshi
    Hosokawa, Ayumu
    Sakai, Tatsunori
    Sakai, Kenji
    Oda, Hisanobu
    Kawahira, Machiko
    Arita, Shuji
    Honda, Takuya
    Taguchi, Hiroki
    Tsuneyoshi, Kengo
    Kawaguchi, Yasunori
    Fujita, Toshihiro
    Sakae, Takahiro
    Shirakawa, Tsuyoshi
    Mizuta, Toshihiko
    Mitsugi, Kenji
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [3] Interim analysis of the NAPOLEON-2 study: Safety evaluation of nano-liposomal irinotecan with fluorouracil and folinic acid for advanced pancreatic cancer
    Kusano, W.
    Arita, S.
    Shimokawa, M.
    Otsuka, T.
    Shimokawa, H.
    Nakazawa, J.
    Koga, F.
    Oda, H.
    Takeshita, S.
    Kawaguchi, Y.
    Taguchi, H.
    Sakai, T.
    Nishikawa, K.
    Arima, S.
    Ueda, Y.
    Kawahira, M.
    Sakae, T.
    Shirakawa, T.
    Mizuta, T.
    Mitsugi, K.
    ANNALS OF ONCOLOGY, 2023, 34 : S1537 - S1537
  • [4] Multicenter observational study of nanoliposomal irinotecan and fluorouracil/leucovorin in patients with unresectable or recurrent pancreatic cancer (NAPOLEON-2): Final retrospective results.
    Imajima, Takashi
    Shirakawa, Tsuyoshi
    Shimokawa, Mototsugu
    Otsuka, Taiga
    Shibuki, Taro
    Nakazawa, Junichi
    Arima, Shiho
    Miwa, Keisuke
    Koga, Futa
    Kubotsu, Yoshihito
    Ueda, Yujiro
    Hosokawa, Ayumu
    Takeshita, Shigeyuki
    Shimokawa, Hozumi
    Komori, Azusa
    Oda, Hisanobu
    Sakai, Tatsunori
    Arita, Shuji
    Mizuta, Toshihiko
    Mitsugi, Kenji
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 706 - 706
  • [5] Nanoliposomal irinotecan plus fluorouracil and folinic acid in irinotecan-pretreated vs. -naive pancreatic cancer patients: A retrospective cohort study
    Schoenlein, M.
    Stein, A.
    Tintelnot, J.
    Nilsson, S.
    Reichelt, R.
    Borchardt, J.
    Schnell, R.
    Goekkurt, E.
    Bokemeyer, C.
    Sinn, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 224 - 225
  • [6] Nanoliposomal irinotecan with fluorouracil and folinic acid, S-1 alone, or FOLFIRINOX as second-line chemotherapy for advanced pancreatic cancer after gemcitabine plus nabpaclitaxel: A pooled analysis of NAPOLEON-1 and NAPOLEON-2
    Otsuka, T.
    Shirakawa, T.
    Shimokawa, M.
    Shibuki, T.
    Nakazawa, J.
    Arima, S.
    Miwa, K.
    Koga, F.
    Kubotsu, Y.
    Ueda, Y.
    Hosokawa, A.
    Takeshita, S.
    Shimokawa, H.
    Komori, A.
    Kawahira, M.
    Oda, H.
    Sakai, T.
    Arita, S.
    Mizuta, T.
    Mitsugi, K.
    ANNALS OF ONCOLOGY, 2022, 33 : S1473 - S1473
  • [7] Final results of multicenter prospective observational study of nano-liposomal irinotecan, fluorouracil and folinic acid in second-line chemotherapy for advanced pancreatic cancer: The NAPOLEON-2
    Toyodome, K.
    Arima, S.
    Shimokawa, M.
    Otsuka, T.
    Nakazawa, J.
    Shimokawa, H.
    Koga, F.
    Oda, H.
    Takeshita, S.
    Kawaguchi, Y.
    Arita, S.
    Nishikawa, K.
    Jikuya, K.
    Sakai, T.
    Sawase, H.
    Ueda, Y.
    Araki, N.
    Shirakawa, T.
    Mizuta, T.
    Mitsugi, K.
    ANNALS OF ONCOLOGY, 2024, 35 : S144 - S144
  • [8] Comparison of inflammatory markers before and after nanoliposomal irinotecan and fluorouracil with folic acid in patients with pancreatic cancer: results from the NAPOLEON-2 study (NN-2302)
    Araki, Tomonori
    Hayashi, Kohei
    Shimokawa, Mototsugu
    Otsuka, Taiga
    Sonoda, Yuki
    Honda, Takuya
    Shibuki, Taro
    Nakazawa, Junichi
    Arima, Shiho
    Miwa, Keisuke
    Koga, Futa
    Ueda, Yujiro
    Kubotsu, Yoshihito
    Shimokawa, Hozumi
    Takeshita, Shigeyuki
    Nishikawa, Kazuo
    Komori, Azusa
    Otsu, Satoshi
    Hosokawa, Ayumu
    Sakai, Tatsunori
    Oda, Hisanobu
    Kawahira, Machiko
    Arita, Shuji
    Taguchi, Hiroki
    Tsuneyoshi, Kengo
    Fujita, Toshihiro
    Sakae, Takahiro
    Kawaguchi, Yasunori
    Shirakawa, Tsuyoshi
    Mizuta, Toshihiko
    Mitsugi, Kenji
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2025, 17
  • [9] A real-world prospective analysis of the relationship between nanoliposomal irinotecan and fluorouracil with folinic acid and neutropenia in patients with pancreatic cancer (NAPOLEON-2 study, NN-2401).
    Shirakawa, Tsuyoshi
    Araki, Tomonori
    Shimokawa, Mototsugu
    Otsuka, Taiga
    Nakazawa, Junichi
    Shimokawa, Hozumi
    Koga, Futa
    Oda, Hisanobu
    Takeshita, Shigeyuki
    Arima, Shiho
    Arita, Shuji
    Kawaguchi, Yasunori
    Nishikawa, Kazuo
    Taguchi, Hiroki
    Jikuya, Kenichi
    Sakai, Tatsunori
    Ueda, Yujiro
    Sakae, Takahiro
    Mizuta, Toshihiko
    Mitsugi, Kenji
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 762 - 762
  • [10] Treatment Effect and Safety of Nanoliposomal Irinotecan with Fluorouracil and Folinic Acid after Gemcitabine-Based Therapy in Patients with Advanced Pancreatic Cancer: A Multicenter, Prospective Observational Study
    Miki, Masami
    Fujimori, Nao
    Ueda, Keijiro
    Lee, Lingaku
    Murakami, Masatoshi
    Takamatsu, Yu
    Shimokawa, Yuzo
    Niina, Yusuke
    Oono, Takamasa
    Hisano, Terumasa
    Furukawa, Masayuki
    Ogawa, Yoshihiro
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (17)
12345